Search

everythinglearnresearchcommunity

for

Search:↓

The workshop discussed the role of a protein called calreticulin in health and disease, its potential as a treatment target, and its possible use as a disease marker.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

Interleukin-15 can help hair growth and protect hair follicles.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Exosomes can help promote hair growth and may treat hair loss.

Topical tofacitinib is effective and safe for treating alopecia areata.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Type 3 Innate Lymphoid Cells help maintain skin health and balance, and are involved in skin diseases and healing.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Activated PRP injections are effective in treating hair loss and improving hair density.

Online forums help understand men's concerns about baldness and show the need for better support that changes how baldness is viewed.

Natural products show promise for new hair loss treatments.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

People with alopecia areata, a skin disease, generally have a poor quality of life, especially if more of their scalp is affected.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Some treatments like pentoxifylline with topical corticosteroids might work for alopecia areata, but more research is needed to find the best one.

Targeting Vδ1+T-cells may help treat alopecia areata.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Human hair follicle stem cells can be turned into red blood cells.

New therapies for alopecia areata show potential but need more research.

Common skin conditions can greatly affect a person's mental health and social life.

Exosomes from fat-derived stem cells can potentially improve hair growth and could be a new treatment for immune-related hair loss.

Inhibiting Zyxin may help treat androgenetic alopecia by promoting hair growth.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.